Launches New CBD Product Indicuraâ„¢ Pain Cream
Jacksonville, FL, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- mCig, Inc. (MCIG), a diversified company servicing industrial hemp and legal cannabis markets, reports today that the 2018 Farm Bill has passed both chambers of Congress, with overwhelming bipartisan support. The bill includes a provision involving industrial hemp and its derivative, cannabidiol (CBD), effectively removing CBD from the Controlled Substances Act Scheduling and putting it under the supervision of the Department of Agriculture.
mCig has long-standing interest and investment in the CBD market, which is expected to reach $2.1 billion by 2020. To celebrate this historic moment in hemp history, mCig is proud to announce one of its subsidiaries, RedFern Biosystems Inc.’s, launch of a new CBD skin and pain care line, Indicura.
“The Indicura line combines an expert blend of hemp CBD extract and bioactive phyto-botanicals ideal for deep muscle relief and skin recovery. Together, these compounds counteract deep tissue damage while promoting regeneration and local circulation. Indicura pairs well with an active lifestyle and recovery after injury,†says Arkady Uryash, MD, Director of Research and Development at mCig.
Indicura’s initial product offering includes a Hemp + Emu Deep Healing Cream and a Hemp + Arnica Cooling Pain Cream. Both are potent blends of CBD and active botanicals that immediately refresh sore muscles and aches. Hemp + Arnica has a frosty, calming effect that provides immediate relief, while Hemp + Emu is deeply penetrating and ideal for sustained use.
“We are excited to announce the Indicura brand as both a skin care and topical pain management brand. We will continue to expand our health and wellness lines in 2019 to include more products. We expect Indicura to be enthusiastically received by our affiliates and customers,†says Paul Rosenberg, MCIG’s CEO.
For more information about the new products or to make a purchase, please visit: https://www.cbd.biz/brands/indicura/
About MCIG Group (MCIG)
Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp, and CBD markets via its lifestyle brands. mCig, Inc. is committed to being the leading distributor of technology, products, and services to fit the needs of a rapidly expanding industry.
About RedFern Biosystems, Inc.
RedFern Biosystems is a leader in advanced science formulation and extraction, determined to bring the health benefits of hemp and cannabinoids to mainstream, cross-category products. RedFern envisions a future in which hemp and cannabis infusions are cornerstones of a healthy, natural lifestyle, and where you can find them on every aisle of your local grocer.
Safe Harbor Statement:
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.
Contact:
Paul Rosenberg
Attn: Chief Executive Officer
[email protected]